Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

PHIO

Insider Sentiment (TTM):

Last Purchase:2026-06-26Last Sale:-Shares Purchased (TTM):30,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:613,948Shares Outstanding:11,617,250Institutional Ownership Pct.:5.28%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	13	17	21	11	11	13	5	5	5	6	8	8
Assets Current
Assets Current	14	17	21	11	11	13	6	6	5	7	9	9
Cash	-	-	-	-	-	-	-	-	-	-	8	8
Prepaid Expense And Other Assets Current	1	0	0	1	1	0	0	0	1	0	1	1
Restricted Cash	-	-	-	-	-	-	-	-	-	-	0	0
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Assets	14	17	21	12	11	13	6	6	5	7	9	10
Operating Lease Right Of Use Asset	-	-	-	-	-	-	0	0	0	0	0	0
Other Assets Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Accounts Payable Current	1	0	0	1	0	0	0	0	0	0	1	0
Liabilities Current
Accrued Liabilities Current	1	1	1	1	1	1	1	1	1	1	1	2
Liabilities Current	-	-	-	-	1	1	1	1	2	1	2	2
Liabilities And Stockhold…
Liabilities	2	1	1	2	1	1	1	-	-	-	2	2
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	-	-
Operating Lease Liability Current	-	-	-	-	-	-	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	176	176	175	163	160	160	151	150	147	147	147	145
Retained Earnings Accumulated Deficit	-163	-159	-155	-153	-150	-148	-146	-145	-143	-141	-139	-137
Liabilities And Stockholders Equity	14	17	21	12	11	13	6	6	5	7	9	10
Stockholders Equity
Stockholders Equity	13	16	20	10	10	12	5	5	4	6	8	7
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	0	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	-	-	0	0	0	0	-	-
Preferred Stock Shares Authorized	10	10	10	10	-	-	10	100	100	100	-	-
Preferred Stock Shares Issued	0	0	0	0	-	-	0	0	0	0	-	-
Preferred Stock Shares Outstanding	0	0	0	0	-	-	0	0	0	0	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	12	12	12	6	5	5	2	1	1	1	0	0
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	0	-	-	-	0	0
Shares Outstanding	12	12	12	6	5	5	2	1	1	1	0	0
Temporary Equity Shares Authorized	-	-	-	-	-	-	10	-	-	-	10	0
Temporary Equity Shares Issued	-	-	-	-	-	-	0	-	-	-	0	0
Temporary Equity Shares Outstanding	-	-	-	-	-	-	0	-	-	-	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-2.63%	-14.91%	-8.77%	-	-	-	-	-	-	-	-	-
2025	66.29%	34.83%	30.90%	-6.85%	9.13%	-6.39%	-8.39%	-23.78%	-29.37%	7.69%	1.71%	-6.84%
2024	-5.19%	-10.13%	-42.50%	-0.38%	17.56%	19.08%	27.35%	-11.66%	-7.62%	56.92%	34.62%	74.23%
2023	-	-	-	-6.58%	-33.77%	-42.98%	7.84%	-25.49%	-46.08%	2.40%	14.86%	2.85%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	-	-	-	-	9.36	10.58	5.65	6.38	3.47	5.48	5.71	4.01
Quick Ratio	-	-	-	-	8.93	10.46	5.30	5.87	3.08	5.18	5.20	3.64
Working Capital	-	-	-	-	10.09M	12.17M	4.72M	4.95M	3.77M	5.60M	7.69M	7.00M
Leverage & Debt
Debt to Equity	-	-	-	-	0.12	0.10	0.21	0.19	0.40	0.22	0.21	0.32
Interest Coverage TTM	-	-	-73.76	-66.88	-59.56	-56.40	-139.38	-143.62	-166.00	-177.94	-	-
Debt Ratio	-	-	-	-	0.11	0.09	0.18	0.16	0.29	0.18	0.17	0.24
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-1.48	-1.57	-9.08	-7.49	-17.00	-2.05	-46.76	-43.01
Free Cash Flow Per Share TTM	-1.05	-0.92	-1.34	-1.33	-1.49	-1.48	-9.03	-8.20	-17.76	-2.20	-46.50	-40.95
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	82.13%	61.60%	21.65%	7.20%	-18.33%	-27.86%	-33.96%	-36.38%	-30.37%	-24.61%	-5.70%	-4.41%
EPS Growth (1Y)	-24.83%	-40.09%	-83.99%	-80.59%	-91.31%	-23.29%	-80.58%	-82.58%	-73.79%	-97.91%	-48.56%	-55.40%
Valuation Metrics
P/E TTM	-0.92	-1.30	-0.72	-1.71	-1.59	-0.83	-0.20	-0.46	-0.37	-2.99	-0.15	-0.32
P/B TTM	0.94	0.86	0.31	1.38	1.12	0.46	0.30	0.69	0.84	5.00	0.20	0.51
Market Cap	11.91M	14.17M	6.28M	13.56M	11.27M	5.60M	1.42M	3.42M	3.18M	28.03M	1.58M	3.68M
Enterprise Value	-1.09M	-2.86M	-14.75M	2.86M	492.91K	-7.68M	-3.96M	-1.97M	-1.52M	21.56M	-6.91M	-4.77M
Calculated Values
Free Cash Flow TTM	-12.21M	-10.72M	-7.99M	-7.28M	-7.14M	-6.38M	-7.11M	-8.12M	-9.06M	-10.06M	-10.76M	-11.10M
Net Debt	-13.00M	-17.03M	-21.03M	-10.71M	-10.78M	-13.28M	-5.38M	-5.39M	-4.70M	-6.48M	-8.49M	-8.46M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Purchase

Owner: Bitterman, Robert J

Title: Chairman, Pres. & CEO

Shares: 10,000

Price/Share: $0.99

Value: $9,900.00

Shares Owned: 421,421

Relationship: Director,Officer

Ownership: Direct

2025-12-31Purchase

Owner: Bitterman, Robert J

Title: Chairman, Pres. & CEO

Shares: 5,000

Price/Share: $1.03

Value: $5,150.00

Shares Owned: 291,421

Relationship: Director,Officer

Ownership: Direct

2025-12-23Purchase

Owner: Bitterman, Robert J

Title: Chairman, Pres. & CEO

Shares: 5,000

Price/Share: $1.02

Value: $5,100.00

Shares Owned: 286,421

Relationship: Director,Officer

Ownership: Direct

2025-11-21Purchase

Owner: Bitterman, Robert J

Title: Chairman, Pres. & CEO

Shares: 5,000

Price/Share: $1.14

Value: $5,700.00

Shares Owned: 281,421

Relationship: Director,Officer

Ownership: Direct

2025-11-18Purchase

Owner: Bitterman, Robert J

Title: Chairman, Pres. & CEO

Shares: 5,000

Price/Share: $1.27

Value: $6,350.00

Shares Owned: 276,421

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Bitterman, Robert J	Director,Officer	Chairman, Pres. & CEO	Direct	Purchase	10,000	0.99	$9,900.00	421,421	4
2025-12-31	Bitterman, Robert J	Director,Officer	Chairman, Pres. & CEO	Direct	Purchase	5,000	1.03	$5,150.00	291,421	4
2025-12-23	Bitterman, Robert J	Director,Officer	Chairman, Pres. & CEO	Direct	Purchase	5,000	1.02	$5,100.00	286,421	4
2025-11-21	Bitterman, Robert J	Director,Officer	Chairman, Pres. & CEO	Direct	Purchase	5,000	1.14	$5,700.00	281,421	4
2025-11-18	Bitterman, Robert J	Director,Officer	Chairman, Pres. & CEO	Direct	Purchase	5,000	1.27	$6,350.00	276,421	4
2025-06-10	Bitterman, Robert J	Director,Officer	Chairman, Pres & CEO	Direct	Purchase	2,000	2.42	$4,840.00	27,149	4
2025-06-10	Ferrara, Robert L	Director	-	Direct	Purchase	2,500	2.42	$6,050.00	15,666	4
2025-06-09	Bitterman, Robert J	Director,Officer	Chairman, Pres & CEO	Direct	Purchase	1,500	2.75	$4,125.00	25,149	4
2025-05-22	Bitterman, Robert J	Director,Officer	Chairman, Pres & CEO	Direct	Purchase	1,200	1.78	$2,136.00	23,649	4
2025-05-20	Ferrara, Robert L	Director	-	Direct	Purchase	2,500	1.82	$4,550.00	13,166	4
2024-06-07	Bitterman, Robert J	Director,Officer	President & CEO	Direct	Purchase	1,000	0.74	$740.00	20,990	4
2024-06-06	Bitterman, Robert J	Director,Officer	President & CEO	Direct	Purchase	1,000	0.75	$750.00	19,990	4
2024-02-26	Bitterman, Robert J	Director,Officer	President & CEO	Direct	Purchase	2,500	0.91	$2,275.00	18,990	4
2023-07-01	Bitterman, Robert J	Director,Officer	President & CEO	Direct	Purchase	1,000	2.84	$2,840.00	19,211	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

5.28%

Inst. Shares: 613,948

Shares Outstanding: 11,617,250

2025-12-31

5.91%

Inst. Shares: 353,634

Shares Outstanding: 5,984,017

2025-09-30

3.45%

Inst. Shares: 188,486

Shares Outstanding: 5,468,584

2025-06-30

3.14%

Inst. Shares: 150,438

Shares Outstanding: 4,794,857

2025-03-31

2.34%

Inst. Shares: 100,618

Shares Outstanding: 4,307,264

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	613,948	11,617,250	5.28%
2025-12-31	353,634	5,984,017	5.91%
2025-09-30	188,486	5,468,584	3.45%
2025-06-30	150,438	4,794,857	3.14%
2025-03-31	100,618	4,307,264	2.34%
2024-12-31	70,678	787,466	8.98%
2024-09-30	28,506	990,033	2.88%
2024-06-30	153,881	510,188	30.16%
2024-03-31	105,403	4,580,072	2.30%
2023-12-31	452,654	231,508	195.52%
2023-09-30	252,902	271,129	93.28%
2023-06-30	249,344	192,054	129.83%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Phio Pharmaceuticals Corp. (PHIO) — SEC Financial Statements & Analysis

Phio Pharmaceuticals Corp. (PHIO) is a pharmaceutical preparations company, incorporated in DE. Phio Pharmaceuticals Corp. trades on Nasdaq as: PHIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Phio Pharmaceuticals Corp. reported a Debt-to-Equity ratio of 0.12x, a Price-to-Book (P/B) ratio of 0.94x (TTM), at a market cap of $11.91M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.12x
P/B TTM: 0.94x
Market Cap: $11.91M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Phio Pharmaceuticals Corp. in?

Phio Pharmaceuticals Corp. (PHIO) operates in the Pharmaceutical Preparations industry.

What is PHIO's market cap?

Phio Pharmaceuticals Corp. (PHIO) has a market capitalization of $11.91M as of 2026-06-30.

What exchange does PHIO trade on?

Phio Pharmaceuticals Corp. (PHIO) trades on the Nasdaq.

Where is Phio Pharmaceuticals Corp. incorporated?

Phio Pharmaceuticals Corp. is incorporated in DE.